The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step This is one of the biggest peptide regulatory shifts in years. And it's just getting started. The FDA has taken its first step toward reversing its 2023 stance, removing 12 peptides from BPC 157: The peptide with big claims and scant evidence STAT BPC 157 for athletes and injury treatment: Science, safety, and legal concerns